WallStreetZenWallStreetZen
Analyst Ranking
Bottom 4%
#4359 out of 4529 analysts
Average Return
-19.02%
Win Rate
26%5 out of 19
Risk vs Reward
Poor
Good

Douglas Miehm's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Aurinia Pharmaceuticals IncAUPH
+59.81%$5.15$8.23
2022-11-03 -
2023-11-03
Buy
Bausch & Lomb CorpBLCO
+29.12%$15.35$19.82
2022-07-25 -
2023-07-25
Buy
Aurinia Pharmaceuticals IncAUPH
+25.74%$6.72$8.45
2023-01-03 -
2024-01-03
Buy
Bausch & Lomb CorpBLCO
+23.74%$13.65$16.89
2022-11-02 -
2023-11-02
Buy
Aurinia Pharmaceuticals IncAUPH
+5.70%$10.52$11.12
2022-04-27 -
2023-04-27
Buy

Douglas Miehm Analyst Color

Get additional color on Douglas Miehm's coverage of popular stocks

Douglas Miehm's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Bausch Health Companies IncBHC
12Hold$9.00-15.17%Maintains
a month ago
Aurinia Pharmaceuticals IncAUPH
8Buy$8.00+59.68%Maintains
a month ago
Bausch & Lomb CorpBLCO
6Buy$21.00+21.39%Maintains
8 months ago
Crh Medical CorpCRHM
1HoldN/AN/ADowngrades
3 years ago
Novadaq Technologies IncNVDQ1
1HoldN/AN/ADowngrades
7 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.